Background
What it is, how it developed and why it is discussed
MOTS-c is a mitochondrial-derived peptide identified in research on cellular stress responses and metabolic signalling. Interest in it is relatively recent and human therapeutic evidence remains early.
Evidence
Evidence, limitations and clinical context
South African registration and scheduling for a specific human-use MOTS-c product must be confirmed before supply. Direct sale is disabled by default.
Clinical access
Availability requires regulatory confirmation
Online purchase remains disabled until the exact human-use product, South African registration and scheduling have been verified. A clinical assessment can still be booked to discuss appropriate options.
Clinical assessment Clinician authorisation
